Adherence to calcium channel blocker poisoning treatment recommendations in two Canadian cities

Clinical Toxicology

Volumn 50, Issue 5, 2012, Pages 424-430

  St Onge, Maude ^a   Archambault, Patrick ^b   Lesage, Natalie ^c   Guimont, Chantal ^c   Poitras, Julien ^b   Blais, René ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Hotel Dieu de Levis Hospital   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d Centre Antipoison du Québec   (Canada)

Author keywords

Cardiac support; Cardiovascular; Heart; Other

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ASPIRATION PNEUMONIA; BRAIN HYPOXIA; CANADA; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ILEUS; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER FUNCTION TEST; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; METABOLIC ACIDOSIS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; POISON CENTER; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; RHABDOMYOLYSIS;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM CHANNEL BLOCKERS; FEMALE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; POISON CONTROL CENTERS; PRACTICE GUIDELINES AS TOPIC; QUEBEC; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84861089034     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2012.687741     Document Type: Review

References (12)

1. Lefebvre L. Insuline/glucose dans le traitement de l ' intoxication par les bloqueurs du canal calcique. Bulletin d ' information toxicologique 2007; 23: 1-5.
2. Chuang R, Heard KJ. Types of studies used to support treatment recommendations in medical toxicology. J Med Toxicol 2010; 6:345-348.
3. De Witt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 2004; 23:223-238.
4. Logan J, Harrison MB, Graham ID, Dunn K, Bissonnette J. Evidencebased pressure-ulcer practice: The ottawa model of research use. Can J Nurs Res 1999; 31:37-52.
5. Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: A prospective observational study. Intensive Care Med 2007; 33:2019-2024.
6. Grimshaw J, Eccles M, Thomas R, MacLennan G, Ramsay C, Fraser C, Vale L. Toward evidence-based quality improvement, evidence (and its limitations) of the effectiveness of guidelines dissemination and implementation strategies. J Gen Intern Med 2006; 21:S14-S20.
7. American Academy of Clinical Toxicology. European association of poisons centres and clinical toxicologists, position paper: Gastric lavage. J Toxicol Clin Toxicol 2004; 42:933-943.
8. Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: A systematic review. J Toxicol Clin Toxicol 2003; 41:595-602.
9. Cumpston KL, Aks SE, Sigg T, Pallasch E. Whole bowel irrigation and the hemodynamically unstable calcium channel blocker overdose: Primum non nocere. J Emerg Med 2010; 38:171-174.
10. DeRoos FJ. Calcium channel blockers (Chapter 60). In Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE, eds. Goldfrank ' s Toxicologic Emergencies, Ninth Edition. McGraw New York: Hill Medical; 2011:886.
11. Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol 2011; 49:277-283.
12. Gaddis GM, Greenwald P, Huckson S. Toward improved implementation of evidence-based clinical algorithms: Clinical practice guidelines, clinical decision rules and clinical pathways. Acad Emerg Med 2007; 14:1015-1022.